JNGLX
Price
$65.35
Change
-$0.18 (-0.27%)
Updated
Apr 15 closing price
Net Assets
4.71B
LYFAX
Price
$12.23
Change
-$0.05 (-0.41%)
Updated
Apr 15 closing price
Net Assets
41.04M
Ad is loading...

JNGLX vs LYFAX

Header iconJNGLX vs LYFAX Comparison
Open Charts JNGLX vs LYFAXBanner chart's image
Janus Henderson Global Life Sciences D
Price$65.35
Change-$0.18 (-0.27%)
VolumeN/A
Net Assets4.71B
AlphaCentric Life Sciences & Hlthcare A
Price$12.23
Change-$0.05 (-0.41%)
VolumeN/A
Net Assets41.04M
JNGLX vs LYFAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JNGLX vs. LYFAX commentary
Apr 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Hold and LYFAX is a StrongSell.

Ad is loading...
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.71B vs. LYFAX (41M). LYFAX pays higher dividends than JNGLX: LYFAX (1.93) vs JNGLX (0.34). JNGLX was incepted earlier than LYFAX: JNGLX (26 years) vs LYFAX (5 years). LYFAX (1.91) is less costly to investors than JNGLX (0.80). LYFAX is a more actively managed with annual turnover of: 134.00 vs. JNGLX (35.00). JNGLX (2500) and LYFAX (2500) have matching initial minimum investment requirements. LYFAX annual gain was more profitable for investors over the last year : 6.26 vs. JNGLX (-7.05). LYFAX return over 5 years is better than : 25.95 vs. JNGLX (16.73).
JNGLXLYFAXJNGLX / LYFAX
Total Expense Ratio0.801.6648%
Annual Report Gross Expense Ratio0.801.9142%
Fund Existence26 years5 years-
Gain YTD-3.741-1.995188%
Front LoadN/A6%-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets4.71B41M11,495%
Annual Yield % from dividends0.341.9318%
Returns for 1 year-7.056.26-113%
Returns for 3 years-1.31-7.3418%
Returns for 5 years16.7325.9564%
Returns for 10 years10.38N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OAZIX26.380.20
+0.76%
Oakmark International R6
GCIRX13.95N/A
N/A
Goldman Sachs Intl Eq Insghts R
ESECX29.03N/A
N/A
Eaton Vance Atlanta Capital Sel Eq C
SLAFX27.53N/A
N/A
DWS Latin America Equity S
OFSFX17.84N/A
N/A
Olstein Strategic Opportunities Adviser